Linked Life Data

15162823

Source:http://linkedlifedata.com/resource/pubmed/id/15162823

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-5-27
pubmed:abstractText
The use of chemotherapy in treating retinoblastoma is presently increasing in importance. Because of the rarity of this disease, excellent in vitro chemosensitivity assays are necessary, not only for individualized testing but also for the development of chemotherapy regimens. It is instructive for improving such assays to discuss in vitro chemosensitivitly tests of tumor cells from clinical specimens according to a cell biological perspective. This review will first summarize and discuss the technical problems encountered with several representative in vitro chemosensitivity tests on clinical specimens, including retinoblastoma. The second part of this review will summarize the results of chemosensitivity tests on retinoblastoma specifically.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1341-9625
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-5
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
In vitro chemosensitivity assays of retinoblastoma cells.
pubmed:affiliation
Biotechnology Research Center, The Graduate School of Teikyo University of Science and Technology, Uenohara, Yamanashi 409-0193, Japan. minomata@ntu.ac.jp
pubmed:publicationType
Journal Article, Review